首页> 美国卫生研究院文献>Journal of the Pediatric Infectious Diseases Society >Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency
【2h】

Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency

机译:严重合并免疫缺陷以外的原发性免疫缺陷中的造血干细胞移植。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hematopoietic stem cell transplantation (HSCT) has been the standard of care for infants with severe combined immunodeficiency (SCID) for several decades due to the dismal prognosis early in life without immune reconstitution. In recent years, as HSCT conditioning regimens and supportive care have greatly improved, HSCT is gaining in acceptance for more non-SCID primary immunodeficiencies (PIDs) and outside the early childhood period. In addition, potential donor options for non-SCID PIDs are expanding with increasing success for haploidentical donor transplants. In this brief report of a presentation at the PIDS-St. Jude 2018 conference, PIDs for which transplants are increasingly performed outside of early childhood will be discussed.
机译:几十年来,由于生命早期没有免疫重建的预后不佳,造血干细胞移植(HSCT)一直是重症合并免疫缺陷(SCID)婴儿的护理标准。近年来,由于HSCT的调理方案和支持性护理已大大改善,HSCT已被越来越多的非SCID原发性免疫缺陷(PID)所接受,并且在儿童期以外。此外,随着单倍体供体移植成功的增加,非SCID PID的潜在供体选择正在扩展。在PIDS-St。的演示文稿的简短报告中。在Jude 2018年会议上,将讨论在儿童早期以外越来越多地进行移植的PID。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号